Similar content being viewed by others Background Drugs that inhibit dipeptidyl peptidase-4 (DPP-4) are conventionally regarded as incretin-based agents that enhance the actions of endogenous gastrointestinal hormones (glucose-like peptide-1 [GLP-1] and glucose-dependent insulinotropic polypeptide) to promote the release of insulin from the pancreas [1, 2]
Vlainic, J., Vukelic, I., Perovic, D., et al
And the risks of untreated obesitydiabetes, heart disease, cancerare far more dangerous
30 Billion TFU Akkermansia muciniphila A cutting-edge probiotic strain known for its role in gut barrier integrity, healthy metabolism*
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can bypass breast cancer cell resistance to methotrexate
296 , R493R500 (2009)